The family holding controlling 30 percent of Solvay said on Thursday it had not received any offer for its stake in the Belgian drugs, chemicals and plastics maker, dampening speculation of an imminent merger. The Financial Times reported on Wednesday that French drugmaker Sanofi-Aventis had made a direct approach to family holding Solvac.
0 comments
Post a Comment